Lexapro (Escitalopram) Side Effects: What You Should Know

Why It Matters

Understanding Lexapro’s side‑effect timeline and interaction risks helps clinicians prevent discontinuations, manage withdrawal, and safeguard patients from potentially life‑threatening complications.

Key Takeaways

• Initial week may cause nausea, insomnia, headaches
• Most side effects fade after one to two weeks
• Abrupt discontinuation can trigger withdrawal symptoms
• Blood thinners plus Lexapro raise bleeding risk
• Serotonin syndrome and suicidality are serious warnings

Pulse Analysis

Lexapro (escitalopram) is one of the most prescribed SSRIs for depression and anxiety, yet roughly three‑quarters of users report at least one adverse effect. Common complaints during the first week include nausea, insomnia, headache, dry mouth, and increased sweating, most of which subside within one to two weeks as serotonergic balance stabilizes. Understanding this early‑phase profile helps clinicians set realistic expectations and reduces premature discontinuation. The drug’s favorable safety record is offset by predictable, mild side effects that can be managed through dose timing, food intake, and supportive lifestyle measures.

Stopping Lexapro abruptly is discouraged because the brain’s serotonin system needs a gradual taper to avoid withdrawal phenomena such as agitation, dizziness, flu‑like symptoms, and sleep disruption. Physicians typically reduce the dose over several days or weeks, especially for patients on higher than 10 mg daily. This approach minimizes rebound anxiety and physical discomfort, preserving therapeutic gains while safeguarding against the FDA’s black‑box warning on increased suicidal ideation in younger adults. Patient education on tapering protocols is therefore a critical component of responsible SSRI prescribing.

Lexapro’s interaction profile warrants careful medication reconciliation. Co‑administration with anticoagulants, NSAIDs, or other serotonergic agents heightens the risk of gastrointestinal bleeding and serotonin syndrome, a potentially life‑threatening condition marked by hyperthermia, neuromuscular instability, and altered mental status. Clinicians should screen for over‑the‑counter supplements such as St. John’s wort and monitor for early signs of manic switches or suicidal thoughts, especially during dose adjustments. Proactive monitoring and patient‑specific risk assessment enable clinicians to balance Lexapro’s efficacy against its safety considerations, ensuring optimal outcomes in mental‑health treatment.